Colchicine in Atrial Fibrillation to Prevent Stroke
common.study.values.description
“Colchicine in Atrial Fibrillation to Prevent Stroke”
The purpose of this study is to determine the feasibility of performing a randomized controlled trial to investigate the efficacy of an anti-inflammatory drug, colchicine, at reducing well validated markers of thrombosis (D-dimer) and inflammation (hs-CRP).
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-yes
Drug - Colchicine
Colchicine 0.6mg twice daily
Drug - Placebo
Placebo Colchicine
participant.views.study.view.additional
participant.views.study.view.scientific-title
Targeting Inflammation in Atrial Fibrillation to Prevent Ischemic Stroke: A Feasibility Study Evaluating the Effect of Colchicine on D-dimer and Hs-CRP in Anticoagulated Patients With Atrial Fibrillation
common.study.values.clinical-trial-id
NCT02282098
participant.views.study.view.id
xboONb
